News Archive

The clinical study's home-based design combines on-site nursing visits and mobile technology to embed research into patients' lives.

Building on DCRI’s strong history in building cardiovascular evidence, researchers at the Institute with a wide range of expertise are also considering how cardiovascular disease factors into other

EDITORS' NOTE: This story was updated January 19, 2021 when the study was published in Journal of the American Medical Association.

The IMPACT-AFib trial lays the groundwork for future large-scale trials to be conducted using electronic claims data.

DCRI Executive Director Adrian Hernandez, MD, MHS, called for a platform that will enable clinical research to be embedded into patient care, allowing research to be conducted at patients’ homes.

Results suggest that a subset of high-risk patients may benefit from an initial invasive treatment strategy.

A wide range of stakeholders who attended an April 2019 DCRI Think Tank helped to identify current challenges to developing treatments for chronic kidney disease, as well as make recommendations for strategies to address these challenges.

Since its inception in 2015, the CARRA Registry, for which the DCRI serves as the coordinating center, has provided necessary infrastructure and data to support a wide range of clinical research projects.

Even in the midst of a global pandemic, taking the time to conduct randomized controlled trials is the most rigorous way to build evidence for potential treatments, according to a recent opinion pi

A group of current and former DCRI researchers contributed to a paper in JACC warning against relying on observational data to guide clinical decisions.